Skip to main content
Premium Trial:

Request an Annual Quote

Aussie Cancer Center Buys Whole-Genome Library from Open Biosystems as Part of Open Access Program

NEW YORK (GenomeWeb News) - Australia's Peter MacCullum Cancer Centre purchased a license to Open Biosystems' whole genome human lentiviral shRNAmir library, the company said today.
 
The transaction was made through the company's Open Access RNAi Program. The program gives the hospital access to RNAi technology, updates and upgrades, off-site backups, and a partner-specific technical support team.
 
The whole-genome resource enables the hospital's 265 investigators to target any gene in the human genome with what Open Biosystems calls improved knockdown efficiency and effectiveness.
 
Financial details were not disclosed.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.